Our energies are focused on relieving our partners from the often expensive and cumbersome task of marketing and distributing their products in Africa. It is all we do, so we've gotten really good at it. Sure, it's not the glamorous side of the business, but that fact alone drives most of our would-be competitors elsewhere and leaves us virtually alone in our tiny market niche.
The real essence of our value, though, is the level of service we offer to each of our partners. We are privately owned and operated, and we are committed to building and maintaining a manageable portfolio. These two realities enable us to provide the attention and expertise necessary to each partnership and every project to ensure success and profitability.
While our ownership structure and attention to personal service strengthen the relationships we build, our goal of never growing beyond capacity assures our partners that we hold their interests as squarely as we hold our own. Likewise, our experience working with third-party distribution provides a proven formula for success our partners can trust.
"Trust is essential to productive and profitable partnerships, and we take great pride in building the selective relationships that emerge naturally from our focus on a sizable portfolio of products and services."
A Case of Supply & Demand
The value of Africa's pharmaceutical industry jumped to $20.8 billion in 2013 from just $4.7 billion a decade earlier. That growth is continuing at a rapid pace: we predict the market will be worth $40 billion to $65 billion by 2020 (exhibit). That's good news for multinationals and pharmaceutical companies seeking new sources of growth as developed markets stagnate. It's also good news for patients, who have gained access to medicines previously unavailable on the continent.*
* Source: www.McKinsey.com
The services we provide to grow your business are focused on the principles we embody to grow our network of partnerships. If you have a great portfolio of products, we can help you build on that foundation.
Dymiq holds current contracts with most major wholesalers and distributors, and we maintain an active Authorized Distributors List. Read More
Our energies are focused on relieving our partners from the often expensive and cumbersome task of marketing and distributing their products in Africa. Read More
Our goal of never growing beyond capacity assures our partners that we hold their interests as squarely as we hold our own. Read More
Africa's Pharmaceutical Market Growth
The value of Africa's pharmaceutical industry jumped to $20.8 billion in 2013 from just $4.7 billion a decade earlier. That growth is continuing at a rapid pace.
Source: African development Bank; BMI Research, IMF/World Bank, World Health Organization, McKinsey
More than just a company. A partner in the community.
Community and Social Responsibility
At Dymiq Pharmaceuticals, we recognize that we have a responsibility to impact the communities we operate in. We embrace this responsibility by dedicating a portion of our profits back into our communities through the Dymiq Foundation.
We invest in the future of Africa by supporting social responsibility projects in healthcare, education and humanitarian efforts.